Post-Marketing Surveillance/Late-Phase
The DCRI provides the insight, experience, and efficiency to optimize your research investment. Our late-phase clinical trials teams understand that there are many study and design variables and will align and customize their processes to deliver cost-effective results that meet your objectives.
Services
Our teams include specially trained and dedicated project managers as well as experts in health outcomes, epidemiology, biostatistics, and post-marketing regulations.
For all of our projects, we apply multidisciplinary, data-driven study design and recruitment methodologies, flexible delivery models, and proven processes.
Our services include:
- Post-marketing safety surveillance
- Additional indication or label expansion trials
- Comparative effectiveness studies and outcomes research
- Observational studies; registries
- Risk management programs
